Keyvan Rezaï
Keyvan Rezaï publishes mostly in Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, on topics such as Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.
- World rank
- #1,971,902 of 7,710,434 ranked researchers
- Rank in France
- #86,088 of 324,115
- Works
- 167
- Citations
- 2.9k
- Citations per work
- 17.4
What does Keyvan Rezaï research?
Keyvan Rezaï's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (27%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6539.2%
- Medicine6539.2%
- Everything else5633.5%
- Life Sciences4627.3%
- 1Molecular Biology24% of their works
- 2Oncology21% of their works
- 3Pulmonary and Respiratory Medicine7% of their works
- 4Hematology6% of their works
- 5Radiology, Nuclear Medicine and Imaging6% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe Keyvan Rezaï's research?
The keywords of their largest research topics: Breast Cancer, Transcriptional Regulation, Metastatic Breast Cancer, BET Bromodomains, PROTACs, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and HER2.
- Chronic Lymphocytic Leukemia
- Estrogen
- HDAC Inhibitors
- CDK4/6 Inhibitors
- Diagnosis Criteria
- HER2
- Chemotherapy-Induced Peripheral Neuropathy
- BET Bromodomains
- Transcriptional Regulation
- Breast Cancer
- Metastatic Breast Cancer
- PROTACs
- Taxanes
- Trastuzumab
- International Myeloma Working Group
- Palbociclib
- Histone Deacetylases
- Receptor
- Genomic Aberrations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 19 words, with their numbers
- Breast Cancer433 topics
- Transcriptional Regulation382 topics
- Metastatic Breast Cancer352 topics
- BET Bromodomains281 topic
- PROTACs281 topic
- Chemotherapy-Induced Peripheral Neuropathy201 topic
- Taxanes201 topic
- HER2181 topic
- Trastuzumab181 topic
- Diagnosis Criteria171 topic
- International Myeloma Working Group171 topic
- CDK4/6 Inhibitors151 topic
- Palbociclib151 topic
- HDAC Inhibitors121 topic
- Histone Deacetylases121 topic
- Estrogen101 topic
- Receptor101 topic
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
Where does Keyvan Rezaï work?
Keyvan Rezaï's main affiliation in the publication record is Institut Curie, France.
How many publications and citations does Keyvan Rezaï have?
OpenAlex counts 167 works and 2,914 citations for Keyvan Rezaï, an h-index of 23, ranking #1,971,902 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Keyvan Rezaï. Posts are plain text and can be reported.